Open Pilot of Cognitive Behavioural Therapy for Insomnia in Pregnancy
1 other identifier
interventional
13
1 country
1
Brief Summary
Despite the literature showing cognitive behavioural therapy for insomnia (CBT-I) to be effective in a variety of populations including postpartum women, as well as the demonstrated harmful consequences of sleep disturbances in late pregnancy, no trials have investigated its efficacy during pregnancy. This project will investigate the efficacy and acceptability of cognitive behavioral therapy for insomnia (CBT-I) in pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2014
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedFirst Submitted
Initial submission to the registry
October 23, 2014
CompletedFirst Posted
Study publicly available on registry
November 20, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedSeptember 17, 2018
September 1, 2018
8 months
October 23, 2014
September 13, 2018
Conditions
Outcome Measures
Primary Outcomes (4)
Change in Actigraphy indices from baseline to post-treatment
Actigraphy is recommended as a reliable and useful method of objective sleep assessment, providing information about indices of sleep efficiency, sleep latency, total sleep time, and number and frequency of awakenings
Baseline (Week 1), Post-treatment (Week 7)
Change in Sleep Diary variables from baseline to post-treatment
Participants complete a daily, standardized sleep diary on a weekly basis both during the treatment period, and at baseline and final assessment times to corroborate actigraphy data. Dependent variables derived from this data include total sleep time, time in bed, sleep efficiency, and sleep quality
Baseline (Week 1), Treatment (Weeks 2-6), Post-treatment (Week 7)
Change in Insomnia Severity Index (ISI) scores from baseline to post-treatment
The ISI can be used to assess the severity of sleep onset, sleep maintenance and early wakening problems, sleep dissatisfaction, and one's perceived distress caused by sleep problems. Scores on the ISI range from 0 to 28, with scores ≥ 15 indicating clinical insomnia.
Baseline (Week 1), Post-treatment (Week 7)
Change in Pittsburgh Sleep Quality Index (PSQI) scores from baseline to post-treatment
The PSQI instrument is used in assessing one's sleep quality in the preceding month. It is comprised of 19 self-rated items and 5 questions rated by the roommate or bed partner. The PSQI possesses seven components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medications and daytime dysfunction. PSQI scores range from 0 to 21, with scores greater than 5 indicating poor sleep quality.
Baseline (Week 1), Post-treatment (Week 7)
Secondary Outcomes (1)
Change in Edinburgh Postpartum Depression Scale (EPDS) scores from baseline to post-treatment
Baseline (Week 1), Post-treatment (Week 7)
Study Arms (1)
CBT for Insomnia
EXPERIMENTALParticipants attend 5 weekly sessions of Cognitive Behavioural Therapy for Insomnia for pregnant women, administered by licensed clinical psychologist.
Interventions
Eligibility Criteria
You may qualify if:
- English speaking women
- Over the age of 18
- Between twelve and twenty-eight weeks of gestation
- Identify as experiencing sleep disturbances will be recruited.
You may not qualify if:
- Women who identify as experiencing symptoms of sleep disorders other than insomnia (i.e. restless legs syndrome, obstructive sleep apnea)
- Women who are experiencing a current major depressive episode, or have been diagnosed with bipolar disorder or other disorders that have a psychotic, dissociative, hallucinatory, or delusional component
- Currently taking prescribed medications for sleep problems
- Inability to attend at least 4 out of the 5 weekly therapy sessions, participate in the assessments
- Smoking, drinking alcohol or drug use during pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Calgarylead
- University of Albertacollaborator
Study Sites (1)
University Of Calgary
Calgary, Alberta, T2N1N4, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lianne Tomfohr-Madsen, PhD
University of Calgary
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Psychology
Study Record Dates
First Submitted
October 23, 2014
First Posted
November 20, 2014
Study Start
June 1, 2014
Primary Completion
February 1, 2015
Study Completion
February 1, 2015
Last Updated
September 17, 2018
Record last verified: 2018-09